siRNA, Anti-Human AP2A1, LNA(CAT#: SIRGT04109WQ-LNA)

The product SIRGT04109WQ-LNA is a type of small interfering RNA (siRNA) that targets AP2A1 gene and regulates the expression of gene. The siRNA interferes with the expression of AP2A1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_014203.2; NM_130787.2
Alternative Names ADTAA; AP2-ALPHA; CLAPA1
Related Diseases Histidine Metabolism Disease, Histidinemia
Purification HPLC
Target Gene
Gene ID 160
Uniprot ID O95782

Related Products